2022
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C, Gao Y, Qian F, Zhang C, Lu H, Zou H, Vermund S, Qian H. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Scientific Reports 2022, 12: 20763. PMID: 36456577, PMCID: PMC9714387, DOI: 10.1038/s41598-022-24220-7.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 reinfectionSystematic reviewReinfection incidenceHazard ratioCase reportIncidence ratePrior SARS-CoV-2 infectionSARS-CoV-2 infectionIncidence of reinfectionInfection-naïve individualsRisk of reinfectionSARS-CoV-2 variantsRandom-effects modelSARS-CoV-2Web of ScienceCohort studyReinfection riskReinfection casesPrior infectionLower riskNew infectionsOmicron variantReinfectionInfection incidenceIncidence
1986
Taeniasis Unresponsive to a Single Dose of Niclosamide: Case Report of Persistent Infection with Taenia saginata and a Review of Therapy
Vermund SH, MacLeod S, Goldstein RG. Taeniasis Unresponsive to a Single Dose of Niclosamide: Case Report of Persistent Infection with Taenia saginata and a Review of Therapy. Clinical Infectious Diseases 1986, 8: 423-426. PMID: 3726395, DOI: 10.1093/clinids/8.3.423.Peer-Reviewed Original ResearchConceptsAdverse gastrointestinal effectsMultiple-dose regimensReview of therapyDrug of choiceTaenia solium infectionTaenia saginataGastrointestinal effectsParasitologic cureCure rateSafe therapySingle doseCase reportBroad-spectrum anthelmintic agentPersistent infectionSolium infectionAlternative treatmentParomomycin sulfateConsecutive daysSeparate occasionsNiclosamideTherapyInfectionAnthelmintic agentsDifferent trialsT. saginata